The results showed that SUCLG2-AS1 and JAK1 were downregulated in AML cells compared with normal cells, while miR-17-5p were upregulated in AML cells compared with normal cells (Fig. 4A, B, C). Here, SUCLG2 is linked to acute myeloid leukemia.